Differences between Thiazolidinediones—Do the Lipid Effects Really Matter?
- 1 September 2005
- journal article
- research article
- Published by Mary Ann Liebert Inc in Metabolic Syndrome and Related Disorders
- Vol. 3 (3), 198-201
- https://doi.org/10.1089/met.2005.3.198
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Efficacy and safety of ezetimibe co‐administered with simvastatin in thiazolidinedione‐treated type 2 diabetic patientsDiabetes, Obesity and Metabolism, 2004
- Effect of Rosiglitazone Versus Insulin on the Pancreatic β-Cell Function of Subjects With Type 2 DiabetesDiabetes Care, 2004
- Association of theAPOLIPOPROTEIN A1/C3/A4/A5Gene Cluster With Triglyceride Levels and LDL Particle Size in Familial Combined HyperlipidemiaCirculation Research, 2004
- Dyslipidemia Management in Adults With DiabetesDiabetes Care, 2004
- Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)BMJ, 1998
- A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarctionJAMA, 1996
- Triglyceride‐rich lipoproteins in non‐insulin‐dependent diabetes mellitus: post‐prandial metabolism and relation to premature atherosclerosisEuropean Journal of Clinical Investigation, 1996
- Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991